These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19816958)

  • 21. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
    Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors.
    Kawano Y; Takaue Y; Watanabe T; Abe T; Okamoto Y; Iwai A; Iwai T; Watanabe A; Ito E; Makimoto A; Nakagawa R; Watanabe H; Sato J; Suenaga K; Suzuya H; Ohnishi T; Kanamaru S; Kaneko M; Kuroda Y
    Cancer Res; 1999 Jul; 59(14):3321-4. PubMed ID: 10416586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
    Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
    Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry comparison of CD34+ subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated rhG-CSF.
    Schiødt I; Knudsen LM; Jensen L; Nikolajsen K; Gaarsdal E; Johnsen HE
    Bone Marrow Transplant; 1998 Jun; 21(11):1167-9. PubMed ID: 9645584
    [No Abstract]   [Full Text] [Related]  

  • 28. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands.
    Lombaert IM; Wierenga PK; Kok T; Kampinga HH; deHaan G; Coppes RP
    Clin Cancer Res; 2006 Mar; 12(6):1804-12. PubMed ID: 16551865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells.
    McNiece IK; Briddell RA; Hartley CA; Smith KA; Andrews RG
    Stem Cells; 1993 Jul; 11 Suppl 2():36-41. PubMed ID: 7691326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
    Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
    Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donors.
    Martínez C; Urbano-Ispizua A; Rozman M; Rovira M; Marín P; Montfort N; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Jan; 23(1):15-9. PubMed ID: 10037045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim.
    Martino M; Console G; Irrera G; Callea I; Condemi A; Dattola A; Messina G; Pontari A; Pucci G; Furlò G; Bresolin G; Iacopino P; Morabito F
    J Clin Apher; 2005 Oct; 20(3):129-36. PubMed ID: 15892086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates.
    Larsen SR; Chng K; Battah F; Martiniello-Wilks R; Rasko JE
    Stem Cells; 2008 Nov; 26(11):2974-80. PubMed ID: 18719223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2005 May; 90(5):715-6. PubMed ID: 15921400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of cytokine levels during granulocyte-colony-stimulating factor stem cell mobilization in healthy donors: association with mobilization efficiency and potential predictive significance.
    Lysák D; Hrabětová M; Vrzalová J; Koza V; Navrátilová J; Svoboda T; Jungová A; Topolčan O
    Transfusion; 2011 Feb; 51(2):319-27. PubMed ID: 20804529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.
    Vokurka S; Koza V; Jungova A; Navratilova J; Svoboda T; Jindra P; Steinerova K; Vyrutova R
    Bone Marrow Transplant; 2012 Jun; 47(6):867-8. PubMed ID: 21874056
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF.
    Tanaka M; Yujiri T; Tanaka Y; Mitani N; Tanimura A; Tanizawa Y
    Bone Marrow Transplant; 2012 Aug; 47(8):1143-4. PubMed ID: 22120987
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of filgrastim (recombinant human granulocyte colony stimulating factor) on IgE responses in human asthma: a case study.
    Smith-Norowitz TA; Joks R; Norowitz KB; Chice S; Durkin HG; Bluth MH
    Transfus Apher Sci; 2013 Oct; 49(2):349-53. PubMed ID: 23768686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung injury in a leukemia patient during mobilization of peripheral blood stem cells using granulocyte colony-stimulating factor alone.
    Shi B; Liu L; Ye L
    Ann Hematol; 2012 Mar; 91(3):469-70. PubMed ID: 21647584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.